Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5785
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas ; volume:2 ; number:2 ; day:16 ; month:6 ; year:2009 ; pages:83-87 ; date:7.2009
Journal of hematopathology ; 2, Heft 2 (16.6.2009), 83-87, 7.2009
- Urheber
-
Balague Ponz, Olga
Ott, German
Hasserjian, Robert P.
Elenitoba-Johnson, Kojo S. J.
Leval, Laurence de
Jong, Daphne de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12308-009-0038-8
- URN
-
urn:nbn:de:101:1-2021081508573144157024
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Balague Ponz, Olga
- Ott, German
- Hasserjian, Robert P.
- Elenitoba-Johnson, Kojo S. J.
- Leval, Laurence de
- Jong, Daphne de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Aggressive B‐cell lymphomas with a primary bone marrow presentation
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
The predictive significance of CD20 expression in B-cell lymphomas
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Aggressive B‐cell lymphomas with a primary bone marrow presentation
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
The predictive significance of CD20 expression in B-cell lymphomas
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Aggressive B‐cell lymphomas with a primary bone marrow presentation
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
BET inhibition revealed varying MYC dependency mechanisms independent of gene alterations in aggressive B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas